购物车
您的购物车当前为空
Anti-SLC34A2 (Lifastuzumab)-SMCC-DM1 是一种抗体-药物偶联物 (ADC),由人源性抗SLC34A2抗体Lifastuzumab与连接子SMCC和细胞毒微管抑制剂DM1缀合而成。该ADC的毒性分子和连接子部分为SMCC-DM1。Anti-SLC34A2 (Lifastuzumab)-SMCC-DM1 可用于癌症研究。
Anti-SLC34A2 (Lifastuzumab)-SMCC-DM1 是一种抗体-药物偶联物 (ADC),由人源性抗SLC34A2抗体Lifastuzumab与连接子SMCC和细胞毒微管抑制剂DM1缀合而成。该ADC的毒性分子和连接子部分为SMCC-DM1。Anti-SLC34A2 (Lifastuzumab)-SMCC-DM1 可用于癌症研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 12,000 | 待询 | |
| 5 mg | 待询 | 待询 |
| 产品描述 | Anti-SLC34A2 (Lifastuzumab)-SMCC-DM1 is an antibody-drug conjugate (ADC) composed of the humanized anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab, linked with the SMCC linker and the cytotoxic microtubule inhibitor DM1. The ADC's toxic and linker components are SMCC-DM1. Anti-SLC34A2 (Lifastuzumab)-SMCC-DM1 can be used for cancer research. |
| 反应种属 | Human |
| 应用 | ELISA FACS Functional assay |
| 抗体种类 | Monoclonal |
| 内毒素 | < 1.0 EU/mg |
| 靶点 | NaPi2b |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
对于不同动物的给药剂量换算,您也可以参考 更多